Author:
Tsvetkov I. S.,Kosyreva A. M.,Mkhitarov V. A.,Postovalova E. A.,Khochanskiy D. N.,Makarova O. V.,Bredova O. Y.,Ostrov V. F.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference15 articles.
1. Tishevskaya NV, Maksakov DA, Golovneva ES. Morphological features of sulpiride model of benign prostatic hyperplasia in rats. Eksp. Klin. Urologiya. 2017;(2):16-19. Russian.
2. Tsvetkov IS, Mkhitarov VA. Immunomorphological characteristics experimental chronic autoimmune prostatitis. Ross. Med.-Biol. Vestn. 2010;18(3):10-17. Russian.
3. Ajayi A, Abraham K. Understanding the role of estrogen in the development of benign prostatic hyperplasia. African J. Urol. 2018;24(2):93-97.
4. Cakir SS, Polat EC, Ozcan L, Besiroglu H, Ötunctemur A, Ozbek E. The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia. Prostate Int. 2018;6(2):71-74.
5. Carson C 3rd, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003;61(4, Suppl. 1):2-7.